ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc.

ACAD | NASDAQ
Chart Builder DCF Calculator
$26.39
-$0.90 (-3.30%)
At close: Sep 21, 2026, 4:00 PM ET
$26.39
$0 (+0.02%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$4.67B
Enterprise Value
$3.64B
Beta
0.86
Average Volume
1.63M
Shares Outstanding (Diluted)
172.85M
Shares Change YoY
2.47%
Institutional Ownership
96.66%
Exchange
NASDAQ
ISIN
US0042251084

Price Performance

Price Change 1M
-10.5%
Price Change 3M
16.8%
Price Change 6M
19.9%
Price Change YTD
0.4%
Price Change 1Y
7.6%
Price Change 3Y
12.0%
Price Change 5Y
55.8%
1M CAGR (ann.)
-4.1%
1Y CAGR (ann.)
12.8%
5Y CAGR (ann.)
11.1%
All-Time CAGR
5.6%

Valuation

PE Ratio
11.89
Forward PE
28.59
PEG Ratio
0.18
Forward PEG
0.25
PS Ratio
3.97
Forward PS
3.20
PB Ratio
3.46
P/FCF Ratio
25.92
P/Adj. FCF Ratio
39.34
P/OCF Ratio
23.35
EV/Sales
3.19
EV/EBIT
34.94
EV/EBITDA
31.32
EV/FCF
20.86
Earnings Yield
8.4%
FCF Yield
3.9%
Adj. FCF Yield
2.5%

Financial Health

Net Cash
$956.47M
Total Debt
$73.85M
Cash & Short-Term Investments
$956.47M
Total Assets
$1.74B
Current Ratio
3.39
Quick Ratio
3.30
Debt / Equity Ratio
0.06
Debt / EBITDA
0.64
Debt / FCF
0.42
OCF / Debt
2.63
Interest Coverage
0.00
Altman Z-Score
6.44
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
91.1%
Operating Profit Margin
7.6%
EBITDA Margin
10.2%
Net Profit Margin
33.4%
FCF Margin
15.3%
Adj. FCF Margin
10.1%
SBC / Revenue
5.2%
SBC Impact (per share)
-34.1%

Returns

Return on Assets
21.8%
Return on Equity
32.4%
Return on Invested Capital
6.2%
Return on Capital Employed
6.3%
Return on Tangible Assets
23.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
27.4%
Revenue CAGR 5Y
19.7%
Revenue CAGR 10Y
143.3%
EPS CAGR 3Y
82.0%
EPS CAGR 5Y
254.2%
EPS CAGR 10Y
61.3%
FCF CAGR 3Y
31.9%
FCF CAGR 5Y
149.2%
FCF CAGR 10Y
79.5%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
37
EPS Growth Next 3Y
-4.2%
Revenue Growth Next 3Y
15.3%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
$0.21
EPS Growth Est (next Q)
-50.0%
Revenue Est (next Q)
$332.31M
Revenue Growth Est (next Q)
19.3%

Fair Value Estimates

Graham Number
$19.50
Graham Upside
-26.1%
Lynch Fair Value
$55.50
Lynch Upside
110.3%
Price Target
$33.83
Price Target Upside
28.2%

Cash Flow

Operating Cash Flow
$194.3M
Free Cash Flow
$174.39M
Adj. Free Cash Flow
$114.88M
FCF Per Share
$1.02
OCF Per Share
$1.13
OCF/S Ratio
17.1%

Income Statement

Revenue
$1.14B
Gross Profit
$1.04B
Operating Income
$86.37M
EBITDA
$116.12M
Net Income
$380.48M
EPS (Diluted)
$2.22
Revenue / Employee
$1.43M
Profit / Employee
$477.4K
Employees
797

© 2026 bestshares.com. All rights reserved.